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Abstract
Centrosomes are frequently amplified in cancer cells. Increased numbers of centrosomes can give
rise to multipolar spindles in mitosis, and thereby lead to the formation of aneuploid daughter cells.
However, whether centrosome amplification is a cause or a consequence of cancer is unclear. In
contrast, loss of a functional centrosome has been shown to lead to cell cycle arrest. In this review,
the potential mechanisms underlying centrosome amplification and centrosome-dependent cell
cycle regulation are discussed.
Background
The centrosome is the major microtubule organizing
center in proliferating human cells. It is a small organelle
composed of two cylindrically shaped centrioles that are
surrounded by pericentriolar material. The centrosome
duplicates during S-phase: in this process the two centri-
oles separate and serve as templates for the formation of
new daughter centrioles. The duplicated centrosomes
accumulate additional pericentriolar material prior to
mitosis, thus increasing their microtubule nucleating
capacity. Microtubules nucleated from the two centro-
somes interdigitate in an antiparallel manner. These
microtubules are moved apart by plus-end-directed motor
proteins; a mechanism that indirectly pushes the two cen-
trosomes to opposite poles of the cell and that supports
the formation of a bipolar mitotic spindle. Spindle bipo-
larity is essential for the subsequent separation of the
chromosomes into two daughter cells. Failures to separate
chromosomes equally may result in aneuploid cells,
which in turn are a hallmark of most human carcinomas.
Because in many cancerous cells an elevated number of
centrosomes has been detected, a causal link has been dis-
cussed between centrosome number and aneuploidy [1,2]
(see other references therein). Clearly, supernumerary
centrosomes are able to induce the formation of addi-
tional spindle poles during mitosis, thus segregating chro-
mosomes to the extra pole. Because cytokinesis can occur
even in the presence of extra spindle poles, daughter cells
are produced that are missing the full complement of
chromosomes. These daughter cells may not be viable if
essential genetic information is lost. However, when only
single chromosomes are missing, the homologous chro-
mosome of the other parent could compensate. Such loss
of heterozygosity may become a problem, for example if
the remaining chromosome carries mutations in tumor
suppressor genes. Multipolar spindles may also lead to
daughter cells with supernumerary chromosomes,
because cleavage during cytokinesis might occur asym-
metrically, uniting multiple poles into one daughter cell.
Moreover, cells with multipolar spindles might suffer
more frequently from tension defects at kinetochore fib-
ers, or from mono-oriented chromosomes, leading to the
activation of the mitotic checkpoint. If the checkpoint
control cannot be satisfied, the cells risk to abort mitosis,
producing a tetraploid cell.
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Mechanisms leading to centrosome 
amplification
Currently, multiple mechanisms have been discussed that
can lead to centrosome amplification. A leading hypothe-
sis proposes that additional rounds of centrosome dupli-
cation during one cell cycle produces supernumerary
centrosomes. Normally, the centrosome number is closely
controlled by the protease separase that regulates the dis-
connection, or 'disengagement', of the centriole pair dur-
ing anaphase and thereby licences centrosome
duplication during S-phase of the following cell cycle [3].
However, overduplication of centrosomes can occur dur-
ing prolonged S-phases, when DNA replication is inhib-
ited by hydroxyurea [4,5]. In recent years, mounting
evidence indicated that centrosomes can undergo addi-
tional, irregular cycles of duplication even after S-phase, at
the time of DNA repair. In this context, multiple reports
have indicated that genotoxic stress can lead to centro-
some amplification [6-8]. More specifically, uncontrolled
centrosome duplication has been demonstrated to occur
when DNA repair during G2 phase is impaired, due to
Rad51 knockout [9]. Besides Rad51, mutations or defi-
ciencies of other proteins of the DNA repair mechanism
such as BRCA1 and BRCA2 have been linked to centro-
some amplification [10-16]. Moreover, the centrosome
protein centrin 2 has been found to associate with the
xeroderma pigmentosum group C complex that is
involved in DNA repair [17-19]. Centrosome amplifica-
tion seems to be favoured in cells lacking p53, and
requires the activity of cdk2 in complex with cyclin A or
cyclin E [20-23]. These are the cyclins found essential for
regular centrosome duplication [24-27].
In addition to overduplication of centrosomes, other cen-
trosome-related mechanisms have been described to
induce multipolar spindles, such as splitting of centriole
pairs, or the formation of acentriolar microtubule organ-
ising centers due to the accumulation of pericentriolar
material [2,28,29]. A completely different mechanism
leading to centrosome amplification has been proposed
by Meraldi et al. [30]. These authors have shown that fail-
ure of cytokinesis due to overexpression of the kinases
Aurora A, Aurora B, or Plk1 leads to binucleate cells con-
taining two centrosomes. After duplication of their cen-
trosomes as well as their DNA in S-phase, these cells
would enter the next mitosis not only with four centro-
somes but also with an octaploid genome.
Overall, the published literature reports a correlation
between centrosome amplification and cancer. However,
it is unclear whether centrosome amplification is a cause
or rather a consequence of tumorigenesis. Moreover,
multipolar spindles in cells with multiple centrosomes are
expected to lead to frequent chromosome loss and pro-
duce non-viable daughter cells. Therefore, a mechanism
must exist that counteracts multipolarity and that allows
cancer cells with multiple centrosomes to proliferate.
Quintyne et al. [31] reported that the microtubule motor
dynein supports clustering of multiple centrosomes into a
bipolar spindle apparatus. Such a mechanism could help
cancer cells to undergo mitosis and maintain a karyotype
that is optimal for proliferation.
Cell cycle arrest in the absence of a functional 
centrosome
Whereas the presence of centrosomes has been correlated
with proliferation, the loss of centrosomes has been
found to block the cell cycle. Most interestingly, the loss
of centrosomes from human cells did not prevent spindle
formation in mitosis [32]. Instead, cells from which the
centrosome was removed either by microsurgery or by
laser ablation arrested at the following G1-S transition in
the cell cycle [33,34]. Similar effects were seen after inhi-
bition or silencing of several centrosome-associated pro-
teins, such as dynactin, PARP-3, centriolin, and AKAP450
[35-38]. It was unclear, however, why cells would arrest in
G1 after inhibition or removal of the centrosome. The
centrosome could either play an essential role at the tran-
sition to S-phase, or alternatively the absence of an intact
centrosome could trigger the checkpoint control system.
To answer this question, Srsen et al. [39] monitored the
effects of RNA silencing of two centrosome proteins,
PCM-1 and pericentrin. The work indicated that depletion
of either of these centrosome proteins increased the levels
of the checkpoint control protein p53 and consequently
of the cdk-inhibitor p21. The activation of p53 was in turn
mediated by p38/MAP kinase that is known to phosphor-
ylate and stabilize p53 as a response to cellular stress. The
loss of centrosome proteins might therefore constitute a
form of stress that activates p53. Although the loss of a
functional centrosome in this experiment did not arrest
all cells instantly, as half of these cells still proceeded into
S-phase within four days after centrosome protein deple-
tion, it predisposed them to undergo premature senes-
cence. Senescence is a cellular program that responds to
various physiological stresses and that leads to permanent
cell cycle arrest [40]. However, cells undergoing senes-
cence can stay alive for extended periods of time, in con-
trast to apoptotic cells. Contrary to previous belief, the
data of Srsen et al. [39], as well as a recent report by
Uetake et al. (Uetake Y, Lončarek J, Nordberg J, English C,
Khodjakov A, Sluder G: The centrosome in G1 progres-
sion: important, but not essential. Abstract 965, 46th
annual meeting of the American Society for Cell Biology,
San Diego, December 9–13, 2006) indicate that cells
without a functional centrosome may prevent cell cycle
progress due to a general increase of stress, rather than due
to a specific activation of the G1-S checkpoint [41].
Because various kinases and phosphatases, as well as cyc-
lin E and p53, have been localized to the centrosome [42-Cell Division 2006, 1:26 http://www.celldiv.com/content/1/1/26
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44], it seems likely that centrosome defects may interfere
with cellular signalling pathways and therefore trigger a
stress response, although the exact molecular details
remain to be explored.
Differentiation and loss of centrosome function
A correlation between loss of centrosome function and
exit from the cell cycle has also been seen in various dif-
ferentiating cell types during vertebrate development.
For example, in several epithelial cell types of liver, kid-
ney, and intestine, the centrosome ceases to act as the
microtubule organizing center upon polarization.
Instead, centrosome proteins are localized in the apical
region of the cell, or in a ribbon-like zone along the
plasma membrane near the apex, such as in mouse coch-
lear cells [45-47]. A different type of reorganisation is
observed in myoblasts undergoing differentiation into
multinucleate muscle fiber cells. In these cells, centro-
some proteins relocalize from the pericentriolar material
to the outer nuclear surface [48,49]. At the same time,
myoblasts withdraw from the cell cycle and become post-
mitotic. Interestingly, the signalling pathway leading to
the differentiation of myoblasts and several other cell
types, such as adipocytes and intestinal epithelial cells,
has been found to involve the activation of p38/MAP
kinase [50-55]. This means that exit from the cell cycle
during differentiation is triggered by the same pathway as
cell cycle arrest after experimental removal of centrosome
proteins [39]. However, it is unclear whether there is a
causal relationship between centrosome disassembly and
p38-dependent exit from the cell cycle in differentiating
cells. In particular, the observation of morphologically
intact centrosomes in terminally differentiated cells such
as neurons argues against the need of centrosome disas-
sembly for cell cycle exit. Instead, activation of p38/MAP
kinase, and therefore triggering of the signalling cascade
that is also used in p38-dependent stress response, might
activate p53 and p21-dependent cell cycle arrest and at the
same time alter centrosome protein assembly. Consist-
ently, altered solubility and altered assembly of the cen-
trosome protein pericentrin have been seen in cells in
which the stress pathway was activated by heat shock
[56,57]. Such a mechanism would make sense, because
once differentiating cells have withdrawn from the cell
cycle, the spindle-forming activity of the centrosome is no
longer needed, and disassembly or relocalization of cen-
trosome proteins may help the cell in modulating the
microtubule cytoskeleton, to fulfil specialized, differenti-
ation-specific functions.
Conclusion
Supernumerary centrosomes have frequently been found
in a variety of cancer cells. It remains unclear whether
supernumerary centrosomes are the driving force in pro-
liferation and tumorigenesis, or whether centrosome
amplification is a consequence of cancer development. In
contrast, functional inhibition or removal of centrosome
proteins leads to cell cycle arrest under experimental con-
ditions. Understanding the regulatory mechanisms that
link centrosome assembly to the cell cycle should be of
immense value for the development of new strategies in
cancer therapy.
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